Elisa Pirro

529 total citations
22 papers, 437 citations indexed

About

Elisa Pirro is a scholar working on Genetics, Hematology and Infectious Diseases. According to data from OpenAlex, Elisa Pirro has authored 22 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Hematology and 5 papers in Infectious Diseases. Recurrent topics in Elisa Pirro's work include Hemoglobinopathies and Related Disorders (7 papers), Iron Metabolism and Disorders (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Elisa Pirro is often cited by papers focused on Hemoglobinopathies and Related Disorders (7 papers), Iron Metabolism and Disorders (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Elisa Pirro collaborates with scholars based in Italy, United States and Canada. Elisa Pirro's co-authors include Silvia De Francia, Antonio D’Avolio, Francesco Di Carlo, Giovanni Di Perri, Francesca Martino, Jessica Cusato, Silvia Racca, Sarah Allegra, Giuseppe Saglio and Amedeo De Nicolò and has published in prestigious journals such as Biomedicine & Pharmacotherapy, British Journal of Clinical Pharmacology and Journal of Pharmacy and Pharmacology.

In The Last Decade

Elisa Pirro

22 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Pirro Italy 12 153 148 105 81 75 22 437
Yoon Hwan Chang South Korea 15 60 0.4× 131 0.9× 43 0.4× 241 3.0× 99 1.3× 66 618
Jesús Martín Spain 15 68 0.4× 426 2.9× 42 0.4× 254 3.1× 56 0.7× 41 939
Amina Haouala Switzerland 11 195 1.3× 272 1.8× 33 0.3× 146 1.8× 35 0.5× 18 591
Romélia Pinheiro Gonçalves Brazil 12 205 1.3× 205 1.4× 34 0.3× 58 0.7× 12 0.2× 38 402
Muhammad Baluom United States 17 115 0.8× 94 0.6× 91 0.9× 116 1.4× 56 0.7× 20 781
Deanna J. Brackman United States 13 59 0.4× 155 1.0× 35 0.3× 172 2.1× 51 0.7× 18 524
Egarit Noulsri Thailand 13 218 1.4× 203 1.4× 101 1.0× 216 2.7× 60 0.8× 50 695
Scott Fettner United States 12 56 0.4× 60 0.4× 37 0.4× 136 1.7× 39 0.5× 16 570
Mukul Minocha United States 13 56 0.4× 45 0.3× 53 0.5× 151 1.9× 52 0.7× 32 612
Shimaa A. Ahmed Egypt 11 85 0.6× 75 0.5× 82 0.8× 51 0.6× 32 0.4× 29 421

Countries citing papers authored by Elisa Pirro

Since Specialization
Citations

This map shows the geographic impact of Elisa Pirro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Pirro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Pirro more than expected).

Fields of papers citing papers by Elisa Pirro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Pirro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Pirro. The network helps show where Elisa Pirro may publish in the future.

Co-authorship network of co-authors of Elisa Pirro

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Pirro. A scholar is included among the top collaborators of Elisa Pirro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Pirro. Elisa Pirro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allegra, Sarah, Jessica Cusato, Silvia De Francia, et al.. (2019). The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. The Pharmacogenomics Journal. 19(5). 417–427. 7 indexed citations
2.
Allegra, Sarah, Jessica Cusato, Silvia De Francia, et al.. (2018). Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients. Pharmacogenetics and Genomics. 28(9). 199–206. 5 indexed citations
3.
Allegra, Sarah, Jessica Cusato, Silvia De Francia, et al.. (2017). Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. The Pharmacogenomics Journal. 18(3). 506–515. 10 indexed citations
4.
Allegra, Sarah, Jessica Cusato, Silvia De Francia, et al.. (2017). Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children. Pharmacogenetics and Genomics. 28(1). 17–22. 8 indexed citations
5.
Allegra, Sarah, Silvia De Francia, F. Favata, et al.. (2017). Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. British Journal of Clinical Pharmacology. 84(1). 197–203. 44 indexed citations
6.
Allegra, Sarah, Silvia De Francia, F. Favata, et al.. (2017). Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. Clinical and Experimental Pharmacology and Physiology. 44(11). 1083–1088. 18 indexed citations
7.
Allegra, Sarah, Silvia De Francia, F. Favata, et al.. (2017). Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. Biomedicines. 5(4). 66–66. 15 indexed citations
8.
Cusato, Jessica, Silvia De Francia, Sarah Allegra, et al.. (2017). Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma. Journal of Pharmacy and Pharmacology. 69(11). 1524–1530. 8 indexed citations
9.
Tampellini, Marco, Simone Benedetto, Chiara Baratelli, et al.. (2016). Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions. Anticancer Research. 36(10). 5163–5170. 2 indexed citations
10.
Allegra, Sarah, Silvia De Francia, Filomena Longo, et al.. (2016). Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia. Biomedicine & Pharmacotherapy. 84. 1510–1512. 2 indexed citations
11.
Allegra, Sarah, et al.. (2016). Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment. Journal of Pharmacy and Pharmacology. 68(11). 1417–1421. 6 indexed citations
12.
Yang, Zhiqian, Monica Argenziano, Paolina Salamone, et al.. (2016). Preclinical pharmacokinetics comparison between resveratrol 2-hydroxypropyl-β-cyclodextrin complex and resveratrol suspension after oral administration. Journal of Inclusion Phenomena and Macrocyclic Chemistry. 86(3-4). 263–271. 14 indexed citations
13.
Francia, Silvia De, Antonio D’Avolio, Alessandra Ariaudo, et al.. (2013). Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia. Therapeutic Drug Monitoring. 36(3). 410–412. 12 indexed citations
14.
D’Avolio, Antonio, Silvia De Francia, Vittoria Basile, et al.. (2013). Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. Pharmacogenetics and Genomics. 23(6). 293–300. 35 indexed citations
15.
Francia, Silvia De, et al.. (2012). A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. Journal of Chromatography B. 893-894. 127–133. 30 indexed citations
16.
Caterino, Marianna, et al.. (2012). Quantification of Imatinib Plasma Levels in Patients with Chronic Myeloid Leukemia: Comparison Between HPLC–UV and LC–MS/MS. International Journal of Peptide Research and Therapeutics. 19(2). 109–116. 7 indexed citations
17.
Pirro, Elisa, Silvia De Francia, Francesca Martino, et al.. (2011). A New HPLC-UV Validated Method for Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Leukemic Patients. Journal of Chromatographic Science. 49(10). 753–757. 49 indexed citations
18.
Francia, Silvia De, Antonio D’Avolio, Francesca Martino, et al.. (2009). New HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma. Journal of Chromatography B. 877(18-19). 1721–1726. 94 indexed citations
19.
Pirro, Elisa, Francesca Martino, Andrea Elio Sprio, et al.. (2006). A new simple HPLC method for measuring mitotane and its two principal metabolites. Journal of Chromatography B. 837(1-2). 69–75. 27 indexed citations
20.
Mognetti, Barbara, et al.. (2005). Salicylate inhibition of rat mammary carcinogenesis and angiogenesis in female rat compatible with misoprostol administration. International Journal of Oncology. 26(3). 697–702. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoon Hwan Chang Breakdown of academic impact, for papers by Jesús Martín Breakdown of academic impact, for papers by Amina Haouala Breakdown of academic impact, for papers by Romélia Pinheiro Gonçalves Breakdown of academic impact, for papers by Muhammad Baluom Breakdown of academic impact, for papers by Deanna J. Brackman Breakdown of academic impact, for papers by Egarit Noulsri Breakdown of academic impact, for papers by Scott Fettner Breakdown of academic impact, for papers by Mukul Minocha Breakdown of academic impact, for papers by Shimaa A. Ahmed
Rankless by CCL
2026